Ryder Steven — SEC insider filings

SEC reporting owner CIK 1872868. 11 insider filings on record with FilingPulse; latest filed 2026-10-30.

Transaction summary — filings shown

Covers all 11 filings on record, filed 2022-02-09 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
REATA PHARMACEUTICALS INC (RETA)Director3——16
Rallybio Corp (RLYB)Chief Medical Officer4——4
MBX Biosciences, Inc. (MBX)Director3——3
Yarrow Bioscience, Inc. (YARW)Chief Medical Officer1——1

Insider filings — Ryder Steven

FiledFormIssuerReported transactionsSource
2026-10-304Yarrow Bioscience, Inc. (YARW)Grant/award (A): 113,137 (derivative) @ $0EDGAR
2026-06-054MBX Biosciences, Inc. (MBX)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2025-06-064MBX Biosciences, Inc. (MBX)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-02-194Rallybio Corp (RLYB)Grant/award (A): 180,000 (derivative) @ $0EDGAR
2024-09-134MBX Biosciences, Inc. (MBX)Grant/award (A): 15,963 (derivative) @ $0EDGAR
2024-02-164Rallybio Corp (RLYB)Grant/award (A): 120,000 (derivative) @ $0EDGAR
2023-09-264REATA PHARMACEUTICALS INC (RETA)Disposition to issuer (D): 10,907 · Disposition to issuer (D): 1,322 (derivative) · Disposition to issuer (D): 6,038 (derivative) · Disposition to issuer (D): 5,492 (derivative) · Disposition to issuer (D): 441 (derivative) · Disposition to issuer (D): 2,137 (derivative)EDGAR
2023-06-094REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 347 @ $93.61 · Grant/award (A): 1,682 @ $93.61 · Grant/award (A): 441 (derivative) @ $73.68 · Grant/award (A): 2,137 (derivative) @ $0EDGAR
2023-02-064Rallybio Corp (RLYB)Grant/award (A): 119,000 (derivative) @ $0EDGAR
2022-07-124REATA PHARMACEUTICALS INC (RETA)Grant/award (A): 913 @ $32.36 · Grant/award (A): 4,171 @ $32.36 · Grant/award (A): 3,794 @ $32.36 · Grant/award (A): 1,322 (derivative) @ $22.36 · Grant/award (A): 6,038 (derivative) @ $0 · Grant/award (A): 5,492 (derivative) @ $0EDGAR
2022-02-094Rallybio Corp (RLYB)Grant/award (A): 62,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872868 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs